BVXP vs. HVO, OXB, AVCT, 4BB, FUM, FARN, SCLP, REDX, ETX, and PRTC
Should you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include hVIVO (HVO), Oxford Biomedica (OXB), Avacta Group (AVCT), 4basebio (4BB), Futura Medical (FUM), Faron Pharmaceuticals Oy (FARN), Scancell (SCLP), Redx Pharma (REDX), e-therapeutics (ETX), and PureTech Health (PRTC). These companies are all part of the "biotechnology" industry.
Bioventix (LON:BVXP) and hVIVO (LON:HVO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings.
Bioventix has higher earnings, but lower revenue than hVIVO.
Bioventix has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, hVIVO has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500.
Bioventix has a net margin of 65.32% compared to hVIVO's net margin of 4.75%. Bioventix's return on equity of 70.11% beat hVIVO's return on equity.
65.5% of Bioventix shares are owned by institutional investors. Comparatively, 15.7% of hVIVO shares are owned by institutional investors. 8.1% of Bioventix shares are owned by company insiders. Comparatively, 39.0% of hVIVO shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Bioventix had 3 more articles in the media than hVIVO. MarketBeat recorded 4 mentions for Bioventix and 1 mentions for hVIVO. hVIVO's average media sentiment score of 0.67 beat Bioventix's score of 0.04 indicating that hVIVO is being referred to more favorably in the news media.
hVIVO received 31 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 69.89% of users gave hVIVO an outperform vote while only 52.87% of users gave Bioventix an outperform vote.
Summary
Bioventix beats hVIVO on 8 of the 14 factors compared between the two stocks.
Get Bioventix News Delivered to You Automatically
Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BVXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Bioventix Competitors List
Related Companies and Tools